ask="7.13"
ask_size="300"
average_daily_volume="196605"
bid="2.66"
bid_size="2500"
book_value="3.71"
change="+0.06"
change_from_200_day_moving_average="-0.51"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-4.43"
change_From_52_week_low="1.11"
change_in_percent="+2.07%"
close="2.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-10.88"
ebitda="-7.84M"
eps_estimate_current_year="-1.18"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.27"
ex_dividend_date="N/A"
float_shares="468000"
high="2.98"
high_52_weeks="7.39"
last_trade_date="1/25/2017"
last_trade_price="2.96"
last_trade_size="100"
last_trade_time="3:58pm"
low="2.85"
low_52_weeks="1.85"
market_capitalization="28.98M"
moving_average_200_day="3.47"
moving_average_50_day="3.02"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.00"
open="2.89"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-14.79%"
percent_change_from_50_day_moving_average="-1.88%"
percent_change_from_52_week_high="-59.95%"
percent_change_from_52_week_low="+59.99%"
previous_close="2.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.78"
price_per_sales="2.21"
revenue="12.87M"
shares_outstanding="9790000"
short_ratio="1.16"
stock_exchange="NCM"
symbol="KOOL"
volume="30476"
weeks_range_52="1.85 - 7.39"
